Doyle's Rehab Restart Signals Extended Colorado Absence; Lineup Composition Tilts Toward Carrigg

Brenton Doyle went 2-for-4 with an RBI in Triple-A Albuquerque on Thursday, marking the restart of a rehab assignment that collapsed five weeks earlier. The Rockies center fielder hasn't appeared in a Major League game since May 19—a left oblique contusion suffered diving for a fly ball that seemed routine until a follow-up groin strain on the same side derailed his initial June 23 rehab stint on July 4. He's now 65 days into what was supposed to be a contained injury recovery and still working his way back through the minors rather than the majors.

The injuries arrive at a particularly awkward moment for Colorado's roster construction. Doyle, the club's Opening Day starter and a two-time Gold Glove winner (2023–24), has batted .207 with one home run across 43 games when healthy enough to play. That production collapse coincided with reduced playing time—a telling management signal that the front office lacked confidence in his output even before the injuries forced him to the sidelines. In his place, rookie switch-hitter Cole Carrigg has posted a .291/.365/.504 slash line with four home runs and 24 RBIs in 36 games, a clear demonstration that Colorado's outfield has evolved since Opening Day.

The supporting cast adds pressure to any Doyle comeback timeline. Jake McCarthy, Mickey Moniak, and Tyler Freeman occupy regular outfield slots. At Triple-A Albuquerque, the Rockies have prospect Charlie Condon (the organization's No. 3 prospect), along with Jordan Beck and Zac Veen—veterans with Major League experience who represent organizational depth. That crowding means Doyle doesn't have a natural return slot waiting for him in Denver. Even if he clears rehab within the next week, the Rockies face a roster-decision conversation before the August 3 trade deadline, one that could shift multiple pieces rather than simply activate him.

From a betting perspective, this timeline matters. Doyle's absence has already exceeded two months; his presence on the active roster before the trade deadline is far from assured, and even a successful rehab completion wouldn't guarantee immediate playing time. For bettors tracking Colorado's outfield composition and bench depth, Doyle's delayed return effectively locks Carrigg into a larger role. The prop angle isn't Doyle's individual performance—it's the structural impact on who takes at-bats in Colorado's lineup. If Doyle clears rehab without setback and the Rockies keep him, it's a roster move that pressures bench depth and could mean earlier exits for depth outfielders in high-leverage spots. If they trade him or release him, it clarifies the lineup as Carrigg-anchored and more predictable for daily slate construction.

The groin strain recurrence on the same side as the oblique injury is the telling detail. Doyle himself acknowledged the anatomical concern; neither soft-tissue injury has fully resolved, and a premature activation could trigger a third setback. For bettors with calendar visibility into injury timelines, this is a play on organizational caution. Colorado is unlikely to rush him back with the depth it currently has, which means the late-July rehab assignment is likely a multi-week runway before any Major League availability.